Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, AMN Healthcare Services, Inc. (AMN) has a Wall Street consensus price target of $22.88, based on estimates from 17 covering analysts. With the stock currently trading at $19.48, this represents a potential upside of +17.5%. The company has a market capitalization of $987M.
Analyst price targets range from a low of $19.50 to a high of $25.00, representing a 24% spread in expectations. The median target of $23.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 10 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, AMN trades at a trailing P/E of -5.1x and forward P/E of 9.6x. Analysts expect EPS to grow +182.4% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how AMN stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonAMN Healthcare Services, Inc. (AMN) has a consensus 12-month price target of $22.88, implying 17.5% upside from $19.48. The 17 analysts covering AMN see moderate appreciation potential.
AMN has a consensus rating of "Buy" based on 17 Wall Street analysts. The rating breakdown is predominantly bullish, with 10 Buy/Strong Buy ratings. The consensus 12-month price target of $22.88 implies 17.5% upside from current levels.
With a forward P/E of 9.573x, AMN trades at a relatively low valuation. The consensus target of $22.88 implies 17.5% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $25 for AMN, while the most conservative target is $19.5. The consensus of $22.88 represents the median expectation. These targets typically reflect 12-month expectations.
AMN is well covered by analysts, with 17 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 10 have Buy ratings, 6 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AMN stock forecast based on 17 Wall Street analysts shows a consensus price target of $22.88, with estimates ranging from $19.5 (bear case) to $25 (bull case). The median consensus rating is "Buy".
AMN trades at a forward P/E ratio of 9.6x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on AMN, with a "Buy" consensus rating and $22.88 price target (17.5% upside). 10 of 17 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AMN analyst price targets range from $19.5 to $25, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $22.88 consensus represents the middle ground.